fda indications for glp 1 The Use of GLP-1 Agonists in the Management of Cutaneous Disease | JCAD GLP-1 Pipeline Update: May 2026

Learn More from the Experts For deeper insights into Setria's ongoing research and applications, check out our recent podcast interview with Katie Emerson and Tony Miano from Kyowa Hakko, recorded at Expo West 2025

Its role in maintaining overall health cannot be overstated

Provider Clearance Guidelines - Ensure the patient meets all clearance criteria before prescribing.- If the patient has a history of skin sensitivity, recommend starting with the lowest concentration and increasing gradually.- Document all clearance decisions in the patients medical record

Find more products here Visit Our Instagram Page Share your thoughts